Joseph Rabin, MD
Surgery · Baltimore, MDNPI 1639303670
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Xvivo Perfusion Inc. at 51.0% of the total. Reporting peaked in 2023 at $543 and has fallen 77.0% since, to $125 in 2024. That places this record below the midpoint for surgery clinicians in MD, where the typical reported total is $976.
Across 14 payments — averaging $65.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xvivo Perfusion Inc.$468
- Abiomed$200
- Medtronic$89
- Veran Medical Technologies, Inc.$85
- United Therapeutics Corporation$76
Across 41 payments — averaging $29,205 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$1.2M
- F. Hoffmann-la Roche AG$853
What the payments were for
- Travel & lodging$46851%
- Food & beverage$45049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xvivo Perfusion Inc. | 8 | $468 |
| Abiomed | 3 | $200 |
| Medtronic | 1 | $89 |
| Veran Medical Technologies, Inc. | 1 | $85 |
| United Therapeutics Corporation | 1 | $76 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$125
How this compares
$918 in reported general payments places this provider in the 45th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Baltimore
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- John LedonneBaltimore$329K
- Martin MakaryBaltimore$135K
- Murtaza DawoodBaltimore$82K
- Christopher YouBaltimore$79K
- Daniel LubelskiBaltimore$67K
- Stephen YangBaltimore$45K
- Amelia PasleyBaltimore$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.